Related Experiment Videos
Immune-mediated inner ear disease
1Division of Rheumatology, Johns Hopkins Vasculitis Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA. jstone@welch.jhu.edu
Current Opinion in Rheumatology
|January 27, 2000
Summary
Immune-mediated inner ear disease (IMIED) causes sudden hearing loss, vertigo, and tinnitus. Prompt immunosuppression can prevent severe outcomes, but its mechanisms require further study.
Area of Science:
- Otolaryngology
- Immunology
- Rheumatology
Background:
- Immune-mediated inner ear disease (IMIED) presents as subacute sensorineural hearing loss, often with vertigo and tinnitus.
- IMIED can be a primary condition or secondary to systemic autoimmune diseases like lupus or Wegener's granulomatosis.
- The exact pathological mechanisms of IMIED are not fully understood due to challenges in obtaining tissue samples from untreated patients.
Purpose of the Study:
- To review the pathophysiology, clinical evaluation, diagnostic testing, and therapeutic strategies for IMIED.
- To highlight the importance of early diagnosis and treatment in managing IMIED.
- To provide a comprehensive overview of current knowledge regarding IMIED.
Main Methods:
- Literature review of existing studies on IMIED.
- Analysis of clinical presentations and diagnostic approaches.
- Evaluation of immunosuppressive treatment protocols and outcomes.
Main Results:
- IMIED is characterized by rapid onset hearing loss and vestibular symptoms.
- Systemic autoimmune conditions are frequently associated with IMIED.
- Early and aggressive immunosuppressive therapy is crucial for preserving hearing and vestibular function.
Conclusions:
- Prompt diagnosis and aggressive immunosuppression are vital to mitigate the severe consequences of IMIED.
- Further research into IMIED pathophysiology is needed to improve treatment strategies.
- A multidisciplinary approach involving otolaryngology, rheumatology, and immunology is beneficial for managing IMIED.